苏肽生联合红花黄色素治糖尿病周围神经病变的临床观察被引量：3

Clinical Observation of Su Peptide Health Jointly Yellow Pigment Treatment of Diabetic Peripheral Neuropathy

下载PDF

导出

摘要目的评价苏肽生(鼠神经生长因子30ug)联合红花黄色素胺治疗糖尿病周围神经病变(DPN)的临床疗效。方法选择住院治疗的80例2型糖尿病合并DPN患者,随机分成对照组和治疗组各40例。对照组给予甲钴胺治疗;治疗组给予苏肽生和红花黄色素治疗。通过肌电图(EMG)观察治疗前后两组神经传导速度变化,比较两组的临床症状改善情况。结果两组治疗前后的主要临床症状评分差异有统计学意义,治疗组治疗效果更为显著,无论是感觉神经传导速度还是运动神经传导速度改善效果都明显好于对照组,两组比较,差异具有统计学意义(P<0.05)。结论苏肽生联合红花黄色素可显著改善糖尿病周围神经病变的临床症状,值得临床推广应用。

作者陈文俊

机构地区华坪县中医院

出处《现代诊断与治疗》 CAS 2015年第4期768-769,共2页 Modern Diagnosis and Treatment

关键词苏肽生鼠神经生长因子红花黄色素糖尿病周围神经病变

分类号 R587.2 [医药卫生—内分泌]

引文网络
相关文献

参考文献4

1张艳,张敏,陆德宾,陈兵,代灿.136例糖尿病周围神经病变患者截肢原因及特点分析[J].西部医学,2011,23(7):1241-1243. 被引量：4
2葛均波,徐永健.内科学[M].第8版.北京:人民卫生出版社,2013.259～265.
3马学毅.糖尿病神经病变的诊断与治疗[J].中国糖尿病杂志,2002,10(5):300-302. 被引量：140
4Mijnhout GS,Alkhalaf A,Kleefstra N,et al.Alphalipoicacid:anewtreatment for neuropathicpaininpatientswithdiabetes[J].Neth J Med,2010,68(6):158-160.

二级参考文献10

1Wild S, Roglic G, Green A, etal. Global prevalence of diabetesz estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004, 27(5) :1047-1053.
2Calle-Pascual AL, Redondo MJ, Ballesteros M, et al. Nontrau- matic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain [J].Diabetes Metab, 1997, 23(6): 519-523.
3Shojaiefard A, Khorgami Z, Larijani B. Independent risk factors for amputation in diabetic foot [J]. Int J Diabetes Dev Ctries, 2008, 28(2) :32-37.
4Dos Santos VP, da Silveira DR, Caffaro RA. Risk factors for pri- mary major amputation in diabetic patients [J]. Sao Paulo Med J,2006, 124(2) :66-70.
5Boulton AJ, Vinik AI, Arezzo JC, et al. American Diabetes As- sociation. Diabetic neuropathies: a statement by the American Diabetes Association [J]. Diabetes Care, 2005, 28 (4) z 956-962.
6Consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology [J]. Diabetes Care, 1988, 11(7):592-597.
7Chaturvedi N, Stevens LK, Fuller JH, et al. Risk factors, ethnic differences and mortality associated with lower-extremity gan- grene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes [J]. Diabetologia, 2001,44 (2): 65-71.
8Markowitz JS, Gutterman EM, Magee G, et al. Risk of amputa- tion in patients with diabetic foot ulcers: a claims-based study [J]. Wound Repair Regen, 2006, 14(1) :11-17.
9Carlson T, Reed J'F 3rd. A case-control study of the risk factors for toe amputation in a diabetic population [J]. Int J Low Extrem Wounds, 2003, 2(1) :19-21.
10袁南兵,冉兴无.糖尿病周围血管病变对周围神经病变的影响[J].药品评价,2010(21):22-24. 被引量：4